Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity of Trumenba or Penbraya in Bexsero-Primed Young Adults
NCT07197762Phase 4Recruiting
- Sponsor
- Emory University
- Start
- Nov 2025
- Primary completion
- Dec 2026
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of meningococcal group B vaccine, Meningococcal ABCYW vaccine in meningococcal disease, sponsored by Emory University. Started Nov 2025; status: recruiting.
02
Drugs
meningococcal group B vaccineMeningococcal ABCYW vaccine
03
Conditions
meningococcal disease
Beyond the preview
Go deeper on NCT07197762.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07197762.